Join our daily newsletter At The Bell to receive exclusive market insights
- Healthcare technology company Alcidion Group (ALC) has updated the market on its second-quarter activities for the 2020 financial year
- The company has already reached a revenue of $15.4 million, nearly matching the total $16.9 million in sales recorded in for the full 2019 financial year
- This month, two contracts were signed with Calvary Health Care and eHealth NSW, adding a further $1 million to the revenue guidance
- The company aims to launch its medical mobile app in the U.K. by the end of March
- Alcidion remains steady on the market this afternoon, selling shares for 22¢ apiece
Healthcare technology company Alcidion Group (ALC) has updated the market on its second-quarter activities for the 2020 financial year.
The company has already reached a revenue of $15.4 million, nearly matching the total $16.9 million in sales recorded in for the full 2019 financial year.
This month, two contracts have been signed with Calvary Health Care and eHealth NSW, which will add another $1 million to the already recorded $15.4 million in sales.
As a result of the contract, Calvary will use Alcidion’s data warehouse across all of its sites. Meanwhile, eHealth NSW has extended its contract to use Aldicion technology in developing its digital child health record.
Besides its current partnerships, Aldicion is also developing its own products. The company aims to launch its Miya MEMRe technology at the U.K.’s Digital Health Rewired Conference in March.
Miya MEMRe is a mobile electronic medical record (EMR) that gives clinicians the information they need to manage their workload and improve patient safety.
Alcidion believes that it is well placed to become a leader in the digital transformation of healthcare as providers increasingly turn to smart technology.
According to the company, advancing healthcare technology is becoming increasingly important. New technology will assist in eliminating US$1 trillion ($1.49 trillion) in preventable errors.
It says opportunity across its three existing markets exceeds $1 billion and is growing rapidly.
Alcidion remains steady on the market this afternoon, selling shares for 22¢ apiece at 1:12 pm AEDT.
